Amneal Pharmaceuticals rises on annual revenue forecast raise
** Shares of Amneal Pharmaceuticals AMRX.O rise 2.6% to
$7.98
** Co raises annual revenue forecast to $2.70 bln to $2.80
bln from prior view of $2.55 bln to $2.65 bln
** Also lifts lower end of FY adj. profit forecast range to
57 cents - 63 cents per share from 53 cents - 63 cents
previously
** AMRX posts Q2 net revenue of $702 mln, 17% higher than
$599 mln a year ago
** Including session's moves, stock up 27.2% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary